Actualités Goldseek Resources Inc - GSK | Actions Canadian Securities Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Goldseek Announces Maiden Drill Program at Southern Arm (Fenelon) and Expanded Drill Permit

Head Office: 1231 Huron Street, London, Ontario, N5Y 4L1 Goldseek Announces Maiden Drill Program at Southern Arm...

GlaxoSmithKline CFO Interviewed on Q1 2013 Financial Results

GlaxoSmithKline CFO Interviewed on Q1 2013 Financial Results PR Newswire LONDON, April 24, 2013 LONDON, April 24, 2013 /PRNewswire/...

GlaxoSmithKline Sales Down in Q3 against Good Underlying Momentum in the Business

GlaxoSmithKline Sales Down in Q3 against Good Underlying Momentum in the Business GlaxoSmithKline Sales Down in Q3 against Good Underlying...

GlaxoSmithKline 14th Annual IMPACT Awards Seek Greater Philadelphia and Camden Healthcare Nonprofits

Nonprofits Providing Access to Healthcare to Receive Up to $400,000 in Awards - Application Deadline March 29, 2010 PHILADELPHIA, Feb. 15...

GSK 2009 Financial Results Announcement and Teleconference Details

PHILADELPHIA, Feb. 1 /PRNewswire-FirstCall/ -- On Thursday, February 4, 2010, GlaxoSmithKline plc will announce its full year financial results...

GSK Exercises Option to Progress Development of ChemoCentryx's Traficet-EN for the Treatment of Inflammatory Bowel Diseases

LONDON and MOUNTAIN VIEW, Calif., Jan. 11 /PRNewswire/ -- GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Goldseek Resources Inc (GSK)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

GSK Actualités

Goldseek Announces Maiden Drill Program at Southern Arm (Fenelon) and Expanded Drill Permit

GlaxoSmithKline CFO Interviewed on Q1 2013 Financial Results

GlaxoSmithKline Sales Down in Q3 against Good Underlying Momentum in the Business

GlaxoSmithKline 14th Annual IMPACT Awards Seek Greater Philadelphia and Camden Healthcare Nonprofits

GSK 2009 Financial Results Announcement and Teleconference Details

GSK Exercises Option to Progress Development of ChemoCentryx's Traficet-EN for the Treatment of Inflammatory Bowel Diseases

CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women

CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women

FDA approves GlaxoSmithKline's VOTRIENT(TM) for advanced renal cell cancer

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Goldseek Resources Inc (GSK) Actualités

Goldseek Resources Inc (GSK)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

GSK Actualités

Goldseek Announces Maiden Drill Program at Southern Arm (Fenelon) and Expanded Drill Permit

GlaxoSmithKline CFO Interviewed on Q1 2013 Financial Results

GlaxoSmithKline Sales Down in Q3 against Good Underlying Momentum in the Business

GlaxoSmithKline 14th Annual IMPACT Awards Seek Greater Philadelphia and Camden Healthcare Nonprofits

GSK 2009 Financial Results Announcement and Teleconference Details

GSK Exercises Option to Progress Development of ChemoCentryx's Traficet-EN for the Treatment of Inflammatory Bowel Diseases

CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women

CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women

FDA approves GlaxoSmithKline's VOTRIENT(TM) for advanced renal cell cancer

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités